News | Coronavirus (COVID-19) | December 07, 2020

16% of people believe they have developed a medical condition since the coronavirus crisis started but have not seen a doctor because they worry about getting COVID-19

16% of people believe they have developed a medical condition since the coronavirus crisis started but have not seen a doctor because they worry about getting COVID-19

December 7, 2020 — New research* from Zegami, an Oxford based medical image analysis platform, reveals that 29% of people say they have a known and diagnosed medical condition but since the Coronavirus crisis started they have avoided seeing a doctor or visiting hospital because they are worried about contracting COVID-19. In terms of gender, one in three women (34%) and one in four men (24%) admit to this.

Zegami, which has recently developed a system to analyze large numbers of mammograms and identify abnormalities, which is the first stage of breast cancer screening, says its research reveals that as many as 254,000 people with cancer may have avoided seeing their doctor or visiting hospital because of fears around COVID-19.

Zegami’s research also found that 16% of people believe they have developed a medical condition since the coronavirus crisis started but decided not to see a doctor, again because of fears about COVID-19.  Some 101,000 people believe their condition could be cancer.   

In terms of those people who have known diagnosed medical conditions and have avoided seeking medical help during the crisis, 21%  said it was for mental health issues, followed by 14% who said they have skin conditions and 9% who have eye health issues.  Some 7% said it was related to their heart conditions, and 2% to cancer.

Of those people who believe they have developed medical conditions during the crisis but have not sought a medical diagnosis for fear of catching COVID-19,  22% say it is linked to their mental health, followed by 13% who say it is a skin condition. Some 7% fear they have developed a heart condition during the crisis, and 1% - nearly 101,000 people - think they may have cancer.         

Roger Noble, CEO and founder of Zegami said: “Our findings are very alarming. The NHS is currently running a high profile campaign urging people to get medical help if they think they have developed any medical conditions during the crisis, and to keep to any health appointments they have for existing conditions. Its Help Us Help You access campaign is backed by celebrities including TV chefs Gordon Ramsay, Nadiya Hussein, and actress Emma Thompson, and we fully support this.”

Zegami’s newly developed system for analyzing large numbers of mammograms and identifying abnormalities uses the recently announced Medical Imaging Server for DICOM from Microsoft.  The system also allows scientists to develop machine learning models to automate this analysis, making it faster and more accurate.

Initial mammogram data for the system has been sourced from The Cancer Imaging Archive (TCIA)  and consists of 3,486 DICOM (Digital Imaging and Communications in Medicine) images, which while anonymized, includes pathology data, allowing this to be factored into the analysis.  One example of the analysis is a map of the "calcification" breast cancer abnormalities - the system highlights regions distinctly containing examples with little light areas, which are typically the benign (without a callback) instances.

*Zegami commissioned the market research company Consumer Intelligence to survey 1,021 people from across the UK.  They represented the UK’s demographic profile.  Interviews were conducted online between 13 and 16 November 2020.    

For more information: www.zegami.com


Related Content

News | Prostate Cancer

May 13, 2024 — Avenda Health, an AI healthcare company creating the future of personalized prostate cancer care, unveils ...

Time May 13, 2024
arrow
News | Radiology Imaging

May 13, 2024 — National Basketball Association (NBA), the National Basketball Players Association (NBPA), and the Next ...

Time May 13, 2024
arrow
News | Breast Imaging

May 10, 2024 — According to the Summa Cum Laude Award-Winning Online Poster presented during the 124th ARRS Annual ...

Time May 10, 2024
arrow
News | Contrast Media

May 8, 2024 — Swedish biotech company Ascelia Pharma AB has announced that its liver imaging drug candidate, Orviglance ...

Time May 08, 2024
arrow
News | RSNA

May 7, 2024 — The Radiological Society of North America (RSNA) and the Radiological and Diagnostic Imaging Society of ...

Time May 07, 2024
arrow
News | Magnetic Resonance Imaging (MRI)

May 7, 2024 — The Magna Cum Laude Award-Winning Online Poster presented during the 124th ARRS Annual Meeting showed a ...

Time May 07, 2024
arrow
News | ARRS

May 7, 2024 — The American Roentgen Ray Society (ARRS) announced that Philip Costello, MD, the 118th ARRS President and ...

Time May 07, 2024
arrow
News | Radiology Business

May 6, 2024 — ScreenPoint Medical’s Board of Directors has announced the appointment of Peter Kroese as the new Chief ...

Time May 06, 2024
arrow
News | Treatment Planning

May 6, 2024 — Elekta announced the acquisition of Philips Healthcare’s Pinnacle Treatment Planning System (TPS) patent ...

Time May 06, 2024
arrow
News | Magnetic Resonance Imaging (MRI)

May 6, 2024 — Hvidovre Hospital has the world's first prototype of a sensor capable of detecting errors in MRI scans ...

Time May 06, 2024
arrow
Subscribe Now